These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 9641014)

  • 1. [Long QT syndrome: from clinical discovery to molecular etiopathogenesis].
    Czajkowski V; Kulbertus H
    Rev Med Liege; 1998 Apr; 53(4):199-207. PubMed ID: 9641014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long QT syndrome and short QT syndrome.
    Zareba W; Cygankiewicz I
    Prog Cardiovasc Dis; 2008; 51(3):264-78. PubMed ID: 19026859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular genetics of the long QT syndrome: clinical aspects].
    Sepp R; Csanády M
    Orv Hetil; 1999 Nov; 140(47):2633-8. PubMed ID: 10613047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressants: their effects on cardiac channels, QT prolongation and Torsade de Pointes.
    Sala M; Coppa F; Cappucciati C; Brambilla P; d'Allio G; Caverzasi E; Barale F; De Ferrari GM
    Curr Opin Investig Drugs; 2006 Mar; 7(3):256-63. PubMed ID: 16555686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ionic, molecular, and cellular bases of QT-interval prolongation and torsade de pointes.
    Antzelevitch C
    Europace; 2007 Sep; 9 Suppl 4(Suppl 4):iv4-15. PubMed ID: 17766323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular and ionic mechanism for drug-induced long QT syndrome and effectiveness of verapamil.
    Aiba T; Shimizu W; Inagaki M; Noda T; Miyoshi S; Ding WG; Zankov DP; Toyoda F; Matsuura H; Horie M; Sunagawa K
    J Am Coll Cardiol; 2005 Jan; 45(2):300-7. PubMed ID: 15653031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dispersion of repolarisation and the autonomic system-can we predict torsade de pointes?
    Huikuri H
    Cardiovasc Drugs Ther; 2002 Mar; 16(2):93-9. PubMed ID: 12090901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The electrophysiological mechanism of the long QT syndrome].
    Lucaci L
    Rev Med Chir Soc Med Nat Iasi; 1996; 100(3-4):32-6. PubMed ID: 9455432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Torsade de pointes.
    El-Sherif N; Turitto G
    Curr Opin Cardiol; 2003 Jan; 18(1):6-13. PubMed ID: 12496496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dangerous and life-threatening drugs - practical lessons from the long QT syndrome.
    Schutte D; Obel W
    Cardiovasc J S Afr; 2002; 13(2):54-61. PubMed ID: 11981581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The long QT syndrome and torsade de pointes.
    el-Sherif N; Turitto G
    Pacing Clin Electrophysiol; 1999 Jan; 22(1 Pt 1):91-110. PubMed ID: 9990606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular genetics in the hereditary form of long QT syndrome].
    Georgijević Milić L
    Med Pregl; 2000; 53(1-2):51-4. PubMed ID: 10953551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Torsade de pointes: the clinical considerations.
    Gowda RM; Khan IA; Wilbur SL; Vasavada BC; Sacchi TJ
    Int J Cardiol; 2004 Jul; 96(1):1-6. PubMed ID: 15203254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetics of acquired long QT syndrome.
    Roden DM; Viswanathan PC
    J Clin Invest; 2005 Aug; 115(8):2025-32. PubMed ID: 16075043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular and ionic mechanisms underlying erythromycin-induced long QT intervals and torsade de pointes.
    Antzelevitch C; Sun ZQ; Zhang ZQ; Yan GX
    J Am Coll Cardiol; 1996 Dec; 28(7):1836-48. PubMed ID: 8962574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long QT syndromes and torsade de pointes.
    Viskin S
    Lancet; 1999 Nov; 354(9190):1625-33. PubMed ID: 10560690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular mechanisms underlying the long QT syndrome.
    Antzelevitch C; Shimizu W
    Curr Opin Cardiol; 2002 Jan; 17(1):43-51. PubMed ID: 11790933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-induced QT prolongation and proarrhythmia: an inevitable link?
    Ahmad K; Dorian P
    Europace; 2007 Sep; 9 Suppl 4():iv16-22. PubMed ID: 17766320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low penetrance, subclinical congenital LQTS: concealed LQTS or silent LQTS?
    Varró A; Papp JG
    Cardiovasc Res; 2006 Jun; 70(3):404-6. PubMed ID: 16678140
    [No Abstract]   [Full Text] [Related]  

  • 20. QT prolongation through hERG K(+) channel blockade: current knowledge and strategies for the early prediction during drug development.
    Recanatini M; Poluzzi E; Masetti M; Cavalli A; De Ponti F
    Med Res Rev; 2005 Mar; 25(2):133-66. PubMed ID: 15389727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.